Adynxx Announces Payment Date of Special Cash Dividend Previously Announced by Alliqua BioMedical
10 mai 2019 06h00 HE
|
Adynxx, Inc.
Adynxx announces May 29, 2019 as payment date of previously announced special cash dividend of $1.05 per share to former Alliqua shareholders Adynxx confirms intent to consummate the previously...
Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors
06 mai 2019 11h05 HE
|
Alliqua BioMedical, Inc
SAN FRANCISCO, May 06, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (Nasdaq: ADYX), a clinical-stage biopharmaceutical company leading the development of transcription factor decoy technology and...
Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors
06 mai 2019 06h00 HE
|
Adynxx, Inc.
SAN FRANCISCO, May 06, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (Nasdaq: ADYX), a clinical-stage biopharmaceutical company leading the development of transcription factor decoy technology and...
Adynxx Announces Merger Agreement with Alliqua BioMedical and Provides Business and Clinical Update
22 avr. 2019 08h00 HE
|
Adynxx, Inc.
Adynxx announced plans to merge with Alliqua BioMedical and become a Nasdaq-listed public company in early 2019 Company announced receipt of substantial grant award from the National Institute on...